About Sun Pharmaceutical Industries Limited (SUNPHARMA)
Sun Pharmaceutical Industries Limited is a Drug Manufacturers - Specialty & Generic company operating in the Healthcare sector. The company is headquartered in Mumbai, India. SUNPHARMA has been publicly traded since 1996, giving it 30+ years of trading history.
Sun Pharmaceutical Industries Limited (SUNPHARMA) has been publicly traded since 1996, making it a 30-year-old public company. It operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. The company is headquartered in Mumbai, India and employs approximately 43,000 people. With a market capitalization of $4.3 trillion, SUNPHARMA is one of the largest publicly traded companies.
SUNPHARMA trades on the Indian stock exchanges (NSE/BSE) and is classified as a mega-cap-cap stock with a market capitalization of approximately $4.3 trillion. The company employs approximately 43,000 people worldwide.
Key Statistics
- Current Price
- ₹1,801.60
- Market Cap
- ₹4.32T
- 52-Week High
- ₹1,851.20
- 52-Week Low
- ₹1,548.00
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
SUNPHARMA Investment Performance
SUNPHARMA has gained 5.4% year-to-date in 2026. Over the past 5 years, a $1,000 investment in SUNPHARMA would have grown to $3,035, representing a 203.5% total return. Since its IPO in 1996, a $1,000 investment would now be worth $1,297,913.
₹1,000 Invested in Sun Pharmaceutical Industries Limited (SUNPHARMA)
How much would ₹1,000 invested in SUNPHARMA be worth today?
What would ₹1,000 invested in SUNPHARMA 1 year ago be worth today?
A ₹1,000 investment in Sun Pharmaceutical Industries Limited (SUNPHARMA) in 2025 would be worth ₹1,130 as of May 2026, representing a +13.1% total return.
What would ₹1,000 invested in SUNPHARMA 3 years ago be worth today?
A ₹1,000 investment in Sun Pharmaceutical Industries Limited (SUNPHARMA) in 2023 would be worth ₹1,882 as of May 2026, representing a +88.2% total return.
What would ₹1,000 invested in SUNPHARMA 5 years ago be worth today?
A ₹1,000 investment in Sun Pharmaceutical Industries Limited (SUNPHARMA) in 2021 would be worth ₹3,035 as of May 2026, representing a +203.5% total return.
What would ₹1,000 invested in SUNPHARMA 10 years ago be worth today?
A ₹1,000 investment in Sun Pharmaceutical Industries Limited (SUNPHARMA) in 2016 would be worth ₹2,404 as of May 2026, representing a +140.4% total return.
What would ₹1,000 invested in SUNPHARMA at IPO be worth today?
A ₹1,000 investment in Sun Pharmaceutical Industries Limited (SUNPHARMA) at IPO would be worth ₹1,297,913 as of May 2026, representing a +129691.3% total return.
Monthly Returns Heatmap
Over the past 30+ years (362 months), Sun Pharmaceutical Industries Limited (SUNPHARMA) has averaged a monthly return of +2.57% with a median return of +2.10%. The stock had 215 positive months (59%) and 147 negative months (41%). The best month in SUNPHARMA's history was March 1999 with a +82.9% return, while the worst was April 2000 at -41.7%. Historically, July tends to be the strongest month (averaging +5.4%), and May the weakest (-0.2%).
SUNPHARMA's longest winning streak was 8 consecutive months of gains, while its longest losing streak was 5 consecutive months of losses. The best full year was 1999 with a cumulative return of +236.0%, and the worst was 2016 at -24.3%.
Annual Returns
Over 30 years of trading history, Sun Pharmaceutical Industries Limited (SUNPHARMA) has delivered an average annual return of +40.82% with a median return of +24.02%. The compound annual growth rate (CAGR) is +26.90%. The stock posted gains in 22 years (73%) and losses in 8 years (27%).
SUNPHARMA's best year was 1999 with a +535.09% gain, while the worst was 2018 at -24.40%. The longest streak of consecutive positive years was 7, and the longest losing streak was 4 years. SUNPHARMA achieved double-digit gains (10%+) in 17 years. It suffered double-digit losses in 3 years.
| Year | Return | Start | End |
|---|---|---|---|
| 2026 | +5.44% | ₹1,708.60 | ₹1,801.60 |
| 2025 | -7.98% | ₹1,856.84 | ₹1,708.60 |
| 2024 | +51.11% | ₹1,228.82 | ₹1,856.84 |
| 2023 | +27.16% | ₹966.35 | ₹1,228.82 |
| 2022 | +19.74% | ₹807.06 | ₹966.35 |
| 2021 | +44.40% | ₹558.91 | ₹807.06 |
| 2020 | +38.20% | ₹404.44 | ₹558.91 |
| 2019 | +1.13% | ₹399.92 | ₹404.44 |
| 2018 | -24.40% | ₹528.99 | ₹399.92 |
| 2017 | -8.73% | ₹579.60 | ₹528.99 |
| 2016 | -23.09% | ₹753.57 | ₹579.60 |
| 2015 | -0.44% | ₹756.92 | ₹753.57 |
| 2014 | +45.92% | ₹518.74 | ₹756.92 |
| 2013 | +54.85% | ₹334.99 | ₹518.74 |
| 2012 | +48.87% | ₹225.02 | ₹334.99 |
| 2011 | +3.35% | ₹217.72 | ₹225.02 |
| 2010 | +61.98% | ₹134.41 | ₹217.72 |
| 2009 | +43.44% | ₹93.70 | ₹134.41 |
| 2008 | -10.95% | ₹105.23 | ₹93.70 |
| 2007 | +32.79% | ₹79.24 | ₹105.23 |
| 2006 | +45.05% | ₹54.63 | ₹79.24 |
| 2005 | +23.43% | ₹44.26 | ₹54.63 |
| 2004 | +87.87% | ₹23.56 | ₹44.26 |
| 2003 | +100.55% | ₹11.75 | ₹23.56 |
| 2002 | +5.88% | ₹11.09 | ₹11.75 |
| 2001 | +7.64% | ₹10.31 | ₹11.09 |
| 2000 | -4.82% | ₹10.83 | ₹10.31 |
| 1999 | +535.09% | ₹1.71 | ₹10.83 |
| 1998 | +24.61% | ₹1.37 | ₹1.71 |
| 1997 | -3.38% | ₹1.42 | ₹1.37 |
SUNPHARMA Investment Analysis: Valuation, Risk & Dividends
Key factors to consider when evaluating Sun Pharmaceutical Industries Limited as an investment
Valuation
SUNPHARMA currently trades at a trailing P/E ratio of 39.5, which is considered high relative to the broader market. The forward P/E of 31.7 suggests analysts expect earnings to be lower in the coming year. The price-to-book ratio stands at 5.6. The price-to-sales ratio is 7.6.
Dividends
Sun Pharmaceutical Industries Limited pays a dividend to shareholders with a current yield of 0.92%. This translates to $16.50 per share annually. The payout ratio of 35% indicates sustainable dividend coverage.
Risk & Volatility
SUNPHARMA has a beta of 0.12, indicating it is less volatile than the overall market. The stock's 52-week range is $1548.00 to $1851.20, and it currently trades near its 52-week high.
Analyst Ratings
Based on 37 analyst opinions, SUNPHARMA has a consensus "buy" rating. The average price target of $1976.35 suggests 9.7% upside from current levels.
Frequently Asked Questions: SUNPHARMA
What sector is SUNPHARMA in? ▼
SUNPHARMA operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry. This sector includes pharmaceutical companies, biotechnology firms, medical device manufacturers, and healthcare providers.
How has SUNPHARMA performed historically? ▼
Over 30 years of trading history, SUNPHARMA has posted gains in 22 years (73% of the time). The best year was 1999 with a +535.1% return. Past performance does not guarantee future results.
How can I invest in SUNPHARMA? ▼
You can invest in SUNPHARMA through any brokerage account that offers access to Indian exchanges. Popular options include commission-free brokers like Fidelity, Charles Schwab, or Robinhood (US), or international brokers like Interactive Brokers. You can buy individual shares or invest through ETFs that hold SUNPHARMA.
Does SUNPHARMA pay dividends? ▼
Sun Pharmaceutical Industries Limited pays a dividend to shareholders with a current yield of 0.92%. This translates to $16.50 per share annually. The payout ratio of 35% indicates sustainable dividend coverage.
What does Sun Pharmaceutical Industries Limited do? ▼
Sun Pharmaceutical Industries Limited is a Drug Manufacturers - Specialty & Generic company operating in the Healthcare sector. The company is headquartered in Mumbai, India.
What sector is SUNPHARMA in? ▼
SUNPHARMA operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
When did SUNPHARMA go public? ▼
Sun Pharmaceutical Industries Limited went public in 1996, making it a 30-year-old public company as of 2026.
How much would $1,000 invested in SUNPHARMA 5 years ago be worth today? ▼
A $1,000 investment in SUNPHARMA five years ago would be worth approximately $3,035 today, representing a 203.5% return.
Does SUNPHARMA pay dividends? ▼
Yes, Sun Pharmaceutical Industries Limited pays a dividend with a current yield of 0.92%, which is $16.5 per share annually.
What is SUNPHARMA's market cap? ▼
Sun Pharmaceutical Industries Limited has a market capitalization of $4.3 trillion, classifying it as a mega-cap company.
What is SUNPHARMA's P/E ratio? ▼
SUNPHARMA has a trailing P/E ratio of 39.5 and a forward P/E of 31.7, which measures how much investors are paying per dollar of earnings.
Is SUNPHARMA a buy, hold, or sell? ▼
Based on 37 opinions, SUNPHARMA has a consensus "buy" rating. The average price target is $1976.35.
Last updated: 3/14/2026